Tofacitinib is Effective in Treating Refractory Immune Checkpoint Inhibitor Hepatitis
Mike Wang, Kerry L. Reynolds, Kamaneh Montazeri, Esperance Schaefer, Ryan J. Sullivan, Michael Dougan
Abstract
These were the only 3 patients managed by the Severe Immunotherapy Complications service who were treated with tofacitinib for ICI-hepatitis during that time.
Topics & Concepts
MedicineTofacitinibRefractory (planetary science)Immune checkpointLimitingOncologyImmune systemImmunologyCancer researchImmunotherapyRheumatoid arthritisEngineeringPhysicsAstrobiologyMechanical engineeringCancer Immunotherapy and BiomarkersMelanoma and MAPK PathwaysCAR-T cell therapy research